SNCA: Major genetic modifier of age at onset of Parkinson's disease

被引:31
|
作者
Brockmann, Kathrin [1 ,2 ]
Schulte, Claudia [1 ,2 ,3 ]
Hauser, Ann-Kathrin [1 ,2 ,3 ]
Lichtner, Peter [4 ]
Huber, Heiko [1 ,2 ]
Maetzler, Walter [1 ,2 ,3 ]
Berg, Daniela [1 ,2 ,3 ]
Gasser, Thomas [1 ,2 ,3 ]
机构
[1] Univ Tubingen, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany
[2] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany
[3] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[4] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany
关键词
Parkinson's disease; SNCA; genetics; age at onset; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; BDNF; ASSOCIATION; POLYMORPHISMS; VARIANTS; MUTATION; VARIABILITY; PENETRANCE;
D O I
10.1002/mds.25469
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single-nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. (c) 2013 Movement Disorder Society
引用
收藏
页码:1217 / 1221
页数:5
相关论文
共 50 条
  • [41] Onset age of Parkinson disease
    Inzelberg, R
    Schechtman, E
    Paleacu, D
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 111 (04): : 459 - 460
  • [42] SNCA REP1 and Parkinson's disease
    Shu, Li
    Zhang, Yuan
    Sun, Qiying
    Pan, Hongxu
    Guo, Jifeng
    Tang, Beisha
    [J]. NEUROSCIENCE LETTERS, 2018, 682 : 79 - 84
  • [43] A genetic modifier of symptom onset in Pompe disease
    Bergsma, Atze J.
    In 't Groen, Stijn L. M.
    van den Dorpel, Jan J. A.
    van den Hout, Hannerieke J. M. P.
    van der Beek, Nadine A. M. E.
    Schoser, Benedikt
    Toscano, Antonio
    Musumeci, Olimpia
    Bembi, Bruno
    Dardis, Andrea
    Morrone, Amelia
    Tummolo, Albina
    Pasquini, Elisabetta
    van der Ploeg, Ans T.
    Pijnappel, W. W. M. Pim
    [J]. EBIOMEDICINE, 2019, 43 : 553 - 561
  • [44] A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease
    Kristiansen, Madeleine
    Maple-Grodem, Jodi
    Alves, Guido
    Arepalli, Sampath
    Hernandez, Dena G.
    Iwaki, Hirotaka
    Nalls, Mike A.
    Singleton, Andrew
    Tysnes, Ole-Bjorn
    Toft, Mathias
    Pihlstrom, Lasse
    [J]. MOVEMENT DISORDERS, 2019, 34 (02) : 298 - 299
  • [45] HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study
    V Leduc
    L De Beaumont
    L Théroux
    D Dea
    P Aisen
    R C Petersen
    R Dufour
    J Poirier
    [J]. Molecular Psychiatry, 2015, 20 : 867 - 873
  • [46] HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study
    Leduc, V.
    De Beaumont, L.
    Theroux, L.
    Dea, D.
    Aisen, P.
    Petersen, R. C.
    Dufour, R.
    Poirier, J.
    [J]. MOLECULAR PSYCHIATRY, 2015, 20 (07) : 867 - 873
  • [47] Age at onset of Parkinson's disease in women is associated with age at menopause
    Savettieri, G
    Ragonese, P
    D'Amelio, M
    Callari, G
    Morgante, L
    Salemi, G
    Epifanio, A
    Morgante, L
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S368 - S368
  • [48] α-synuclein (SNCA) variants and Parkinson's disease susceptibility
    Goldman, S. M.
    Tanner, C. M.
    Korell, M.
    Bhudhikanok, G. S.
    Schuele, B.
    Hoppin, J. A.
    Sterling, L.
    Umbach, D. M.
    Ross, G. W.
    Blair, A.
    Langston, J. W.
    Kamel, F.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S33 - S33
  • [49] Targeted resequencing of the SNCA region in Parkinson's disease
    Pihlstrom, L.
    Dietrichs, E.
    Toft, M.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S470 - S470
  • [50] SNCA G51D missense mutation causing juvenile onset Parkinson's disease
    Cooper, C.
    Goldman, J.
    Zabetian, C.
    Mata, I.
    Leverenz, J.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S172 - S172